Rosemont Pharmaceuticals Limited

Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone: +44 (0)113 244 1400
Fax: +44 (0)113 246 0738
WWW: http://www.rosemontpharma.com
Customer Care direct line: +44 (0)800 919 312
Out of Hours Telephone: +44 (0)7836 557 879
Out of Hours contact: pharmacovigilance@rosemontpharma.com

Patient Information Leaflet last updated on the eMC: 02/02/2012
PIL Frusol 20mg/5ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
Updated on 17/08/2009 and displayed until 02/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 26/01/2009 and displayed until 17/08/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 27/08/2008 and displayed until 26/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/04/2008 and displayed until 27/08/2008
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 11/07/2007 and displayed until 14/04/2008
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
  • Change to side-effects
Updated on 30/05/2007 and displayed until 11/07/2007
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 20/12/2005 and displayed until 30/05/2007
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 21/09/2005 and displayed until 20/12/2005
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 31/08/2005 and displayed until 21/09/2005
Reasons for adding or updating:
  • Change to date of revision
Updated on 29/07/2003 and displayed until 31/08/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 25/09/2002 and displayed until 29/07/2003
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   furosemide